A teenager who went into care when he was 10 has described how he struggled to navigate the system and seek help.
Hayden, now aged 17, lived in a children's home until he was 16 before moving into a semi-independent home. After feeling unsafe there he ended up sofa-surfing.
"There is an incredible amount of individuals working so hard to improve the lives of young people but the system is fundamentally flawed," said Hayden, who got in touch with the BBC via Your Voice to share his experience.
A new government-commissioned report found that young adult care-leavers have a death rate about four times higher than the general population.
The report noted the potentially catastrophic consequences for those who are often left alone "with no safety net".

#hayden #care #home

The United States military announced Monday that it struck an alleged drug trafficking boat in the Eastern Pacific, posting a video of the strike on social media. Officials say two people were killed. It marks the first known strike in more than two months.

#strike #eastern #pacific #struck

Ukraine is buying a homegrown glide bomb that could help its pilots strike Russian forces from a safer distance while relying less on weapons supplied by the U.S. and Europe.
The new weapon is called the Vyrivniuvach, or "Equalizer." It was developed by Ukrainian company DG Industry with support from Brave1, a government-backed defense technology group.
A Ukrainian military official told Ukrinform that the bomb has finished testing and is now being bought for the armed forces. Fox News Digital has reached out to Ukraine's Ministry of Defense for more details.
Until now, Ukraine's warplanes have relied heavily on U.S.-supplied JDAM-ER bomb kits and Small Diameter Bombs, as well as French-made Hammer bombs, for precision strikes from safer distances. The Equalizer could give Kyiv more control over its own supply of guided bombs as foreign military aid remains uncertain.
'A New Kind Of War': Inside Ukraine's Hidden Factories Mass-producing Combat Drones

#bombs #bomb #forces #ukraine

Home sales are hitting record highs in many markets and renovations like lawn care and refinished floors can help boost buyer interest. Reporting for TODAY, NBC's Vicky Nguyen asks experts which housing upgrades pay off the most and maximize your return when listing your property.

#nguyen

Inflation fell by 0.4% month-over-month in June and rose by 3.5% year-over-year. NBC News' Allie Canal and Investopedia's Caleb Silver report on the impact inflation may have on your budget.

A US citizen working for a humanitarian group in the Democratic Republic of Congo has tested positive for the Bundibugyo strain of the Ebola virus, the Centers for Disease Control and Prevention said in a statement on Friday.
The CDC said it is working with the patient's employing organization, other federal agencies and partners in the DRC to help prevent further transmission and identify high-risk contacts.
No other details have been released about the patient. CNN has reached out to the CDC and the State Department for comment.
The number of confirmed Ebola cases in the DRC has increased to 1,830 including 648 deaths, government data showed late on Friday, Reuters reported.
No Ebola cases have been confirmed in the United States and "the overall risk to the American public and travelers remains low," according to the latest data published Saturday on the CDC website. The outbreak remains confined to remote areas of the DRC and neighboring Uganda, and the risk of it spreading to the US is "considered very low," it said.

The luxury sector is weathering crosswinds at the moment: On the one hand, military conflict in the Middle East has sent high-earning consumers scattering from the region and purse strings tightening. On the other hand, the emergence of AI and weight-loss medication like GLP-1s means it's never been so easy for consumers to shop for premium brands, and they have an emerging motivation to do so.

The latest Luxury Monitor from global consulting firm Bain & Co shows growth in the sector has dipped slightly (by -1%) year on year, with estimates for Q1 2026 coming in at -3% on a constant exchange rate.

That said, there are green shoots: A major driver of consumption is the use of GLP-1 weight-loss medications, the report authored by Claudia D'Arpizio and Federica Levato, senior partners at Bain & Co, says. The emergence of the trend "is a very central question, and the macro trend in consumption of so many categories within luxury and outside of luxury, from a sociological and anthropological perspective, is the most interesting topic right now," Levato told Fortune.
In the soft luxury category, like apparel and footwear, "there is, of course, the enthusiasm of having lost weight and so there is a direct correlation with 'Let's buy a new wardrobe,'" Levato explains. "There is more enthusiasm for a shopping frenzy … and it's directly related to higher consumer confidence."
Levato isn't talking about consumer confidence in the sense of a brighter economic outlook. Rather, she describes the "YOLO" (you only live once) sentiment among consumers, inspired at first by the end of the pandemic and, since then, new options for self-confidence courtesy of drugs like Ozempic and Mounjaro.
For brands, this raises several questions. Levato suggests the key problem facing the luxury sector is how to broaden its client base, be it by generation, region, or income level. Another effect of widespread use of GLP-1s is that more people may fit the sometimes-limited sizing options offered by luxury brands, Levato says.
The luxury sector has long been criticized for not being inclusive (wealth barriers aside). In the era of weight loss drugs, representation for a range of body types appears to have regressed even further. The Vogue Business Fall/Winter 2026 Size Inclusivity Report, released in March, found that of the nearly 8,000 looks presented in the season, 97.6% were in so-called "straight sizes" of U.S. 0-4. The "mid-size" category (U.S. 6-12) had representation of 2.1%, while plus-sizes (U.S. 14+) were just 0.3%.